Navigation Links
Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference

Evidence Base for MEDIHONEY(TM) Dressings Growing

PRINCETON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that four abstracts detailing the clinical usage of its newly released MEDIHONEY(TM) Wound & Burn Dressings with Active Leptospermum Honey were accepted for presentation at the upcoming annual American Professional Wound Care Association conference, held this year between March 6 - 9 in Forth Worth, Texas. Additionally, the company has announced that the use of MEDIHONEY(TM) Dressings is a topic on the general session agenda for the conference.

About the product's recognition at the upcoming conference, CEO Edward Quilty said, "The fact that so many abstracts were developed and accepted at a national conference after only four months on the market speaks volumes to the effectiveness of the MEDIHONEY(TM) dressings. Based on the response and clinical evidence generated while on the market in Europe over the past two years, we had a good sense of what would happen upon our launch in the US and Canada. It is exciting to see the product meeting our very high expectations, and to know that we are contributing to the well-being of many patients who would otherwise have very few options."

The abstracts include the following:

"Chronic Lower Extremity Ulceration -- Use of a Leptospermum Impregnated Alginate to Accelerate Wound Closure", Dr. Matt Regulski, DPM, Toms River Foot and Ankle Surgical Associates, New Jersey.

"Clinical Application of Absorbent Calcium Alginate Dressing Pads, Containing Manuka (Leptospermum) Honey, in Infected Lower Extremity Venous Ulcers", Dr. Paul Kesselman, DPM, Brooklyn, NY

"Favorable Treatment Outcomes of Chronic Leg Ulcers with the Use of a New Leptospermum Honey Alginate Dressing", Dr. Paul A. Ligouri, MD and Kim L. Peters, RN, CWS, Whittier Rehabilitation Hospital, Haverhill, MA.

"Utilizing Leptospermum Honey Alginate in Treatment of Recalcitrant Lower Extremity Ulcers", Dr. Steven J. Kavros, DPM, Mayo Clinic, Rochester, MN.

In addition to these presentations, the first topic on the conference's general session agenda following the keynote address will be "MEDIHONEY(TM): An Update on the Newly Approved Natural Approach to Chronic Wounds", to be presented by Dr. Robert Frykberg, DPM, FAPWCA, MPH, Chief of Podiatry, Carl T. Hayden VA Medical Center in Phoenix, AZ. In this session Dr. Frykberg will be providing an update on his continuing case series related to the treatment of recalcitrant diabetic foot ulcers with MEDIHONEY(TM) dressings, first presented at the Clinical Symposium on Advances in Skin and Wound Care last October.

MEDIHONEY is the first FDA-cleared honey-based dressing for use on chronic wounds and burns, and is the only FDA-cleared honey-based product currently commercialized. Its key ingredient, Active Leptospermum Honey, has been shown to be effective in a variety of wounds and burns, and was recently the focus of two positive large scale randomized controlled studies on leg ulcers. After four months on the market, the company has made the decision to expand its sales force to meet the high demand for this unique wound care device.

About Derma Sciences

Derma Sciences is a manufacturer and marketer of advanced wound-care products, with operations based in the US and Canada, and sales worldwide. The company recently launched its MEDIHONEY(TM) Wound & Burn dressings with Active Leptospermum Honey. The Company has also obtained FDA clearance to market and sell its MOBILITY-1(TM) boot and compressor device for the treatment of venous ulcers, lymphedema, and other conditions that require compression therapy. For more information about Derma Sciences, Inc., visit its home page on the Internet at

About the APWCA

The American Professional Wound Care Association (APWCA) is a hybrid non-profit organization whose membership incorporates the various medical specialties involved in providing all aspects of wound care. Its seminars bring these fields together and facilitate an integrated, multi-disciplinary approach. The mission of the Association is to help decrease the rate of complications from all wounds, including acute, chronic, post surgical, post radiation, reconstructive and other problematic wounds. The organization's stated goal is to accelerate wound healing and preserve and/or enhance the quality of life for these patients. For more information about the APWCA, visit its home page at

Forward-looking Statements

Statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements which may be made in this release or which are otherwise made by or on behalf of the Company. Factors which may affect the Company's results include, but are not limited to, product demand, market acceptance, impact of competitive products and prices, product development, completion of an acquisition, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements Include but are not limited to, those discussed in the Company's filings with the Securities and Exchange Commission.


Derma Sciences Inc Allen & Caron Inc

Edward J. Quilty Rudy Barrio (US Investors)

Chairman and CEO

(609) 514-4744 Brian Kennedy (media)

(212) 691-8087

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. 1st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia
2. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
3. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
4. AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
5. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
6. Prominent Cosmetic Dermatologist and Author Joins
7. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
8. LOreal USA Announces Three-Year Support of Womens Dermatologic Society Foundation Community Outreach
9. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
10. American Academy of Dermatology Caught in Pay-for-Play Scandal
11. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions ... SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of ... SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates ...
(Date:11/27/2015)... MINNEAPOLIS, Minn. (PRWEB) , ... November 27, 2015 ... ... you start failing. Secura Consultants has prided itself for not only fulfilling the ... best income protection solutions at an affordable price and providing top-tier customer service. ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
(Date:11/27/2015)... Rosa, CA (PRWEB) , ... November 27, 2015 , ... ... Northern California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at ... meeting. They observed that both STEMI and Sepsis conditions present in similar ways and ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
(Date:11/26/2015)... the Netherlands , November 26, 2015 ... A new combination approach blends immunotherapy with ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic ... the Netherlands has found that immunotherapy can ...
(Date:11/26/2015)... --> --> Juntendo University ... contrast weighting of MRI for patients with Multiple Sclerosis ... agreement with SyntheticMR in order to use SyMRI in clinical ... to generate multiple contrast images from a single scan and ... making it possible to both fine tune images and recreate ...
Breaking Medicine Technology: